Types of Participant Sample Clauses

Types of Participant. There are three types of Participant authorised under this Implementing Agreement: Contracting Parties, Sponsors, and Limited Sponsors. In all cases, participation is subject to the terms and conditions found in this Article and any additional conditions established by the Executive Committee, which in neither case shall be inconsistent with those found in the Framework.

Types of Participant. All studies which included women aged 18 years or older who were pregnant at any gestational stage and who meet diagnostic criteria of an anxiety disorder as classified by the Diagnostic Statistical Manual (DSM III, III-R, IV, IV-TR or V) (American Psychiatric Association, 1980, 1987, 1994, 2000; Association, 2013) or the International Classification of Diseases (ICD 9, ICD 10 or ICD 11) (Xxxxxxxxx, 2021; Organization, 1992; Slee, 1978) were included. These must include one or more of the following anxiety disorders: generalised anxiety disorder, separation anxiety, social phobia, panic disorder with or without agoraphobia, health anxiety and specific phobias. Disorders such as post-traumatic stress disorder and obsessive- compulsive disorder were included as anxiety-related disorders (following the re- categorisation that occurred in the DSM-5). Studies were included if a diagnosis was reported in the paper or a diagnosis was made by either a clinical assessment or a standard diagnostic interview such as the Structured Clinical Interview for DSM-IV (SCID-II) (First et al., 1997) or the Mini International Neuropsychiatric Interview (MINI) (Xxxxxxxxx et al., 1997). Comorbid psychiatric diagnoses such as depression were not grounds for exclusion, on the condition that these disorders were considered by the authors to be secondary to the anxiety disorder being treated. This would be reported as a secondary diagnosis in the included study. Women who were pregnant at any stage of gestation at the time of the intervention were eligible. However, any study that looked specifically at completing exposure postnatally was excluded. Treatment programs that started during pregnancy and finished postnatally were considered. Studies with participants with pregnancies that were considered ‘high-risk’ or who experienced medical complications at the start of the intervention were also excluded on the basis of the unknown physiological mechanisms.

Types of Participant is the categorical dependent variable of this first stage and takes a value of 1 to 3 (i.e. j = 1, … , 3), depending the firms’ group and Zi,t −1 is the set of exogenous independent variables used as instruments. In the second stage regression, we use the predicted values of participation and the types of participant to test whether they explained reductions in emissions. We used the changes in rates of CO2 emissions (CO2/Generation) from one year to another to assess the changes in the level of emissions. 10 Of the 124 agreements signed with the DOE, seven agreements were signed at the end of 1995, one agreement in 1996, eight in 1997 and two agreements in 1998. An agreement can represent several firms because they can be signed at the holding level. two consecutive years across the whole period of the program. The U.S. Environmental Protection Agency reports under the Clean Air Market Program the amount of CO2 emissions emitted by each utility. We divide this by the amount of net generation reported on Form EIA-906.  CO2 emissionsi, t   CO2 emissionsi, t-1  Second Stage Dependent variable : Change in CO2 rate =   −      i  Generation i,t   Generation 